1055039-72-9

Basic information

• Product Name: 1-{(2R,3R,4R,4aR,10aR)-4-Hydroxy-6,6,8,8-tetraisopropyl-3-[(4-methoxy-phenyl)-diphenyl-methoxy]-hexahydro-1,5,7,9-tetraoxa-6,8-disila-benzocycloocten-2-yl}-1H-pyrimidine-2,4-dione
• CAS NO: 1055039-72-9
• Molecular Weight: 789.086
• Mol File: 1055039-72-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-{(2R,3R,4R,4aR,10aR)-4-Hydroxy-6,6,8,8-tetraisopropyl-3-[(4-methoxy-phenyl)-diphenyl-methoxy]-hexahydro-1,5,7,9-tetraoxa-6,8-disila-benzocycloocten-2-yl}-1H-pyrimidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-{(2R,3R,4R,4aR,10aR)-4-Hydroxy-6,6,8,8-tetraisopropyl-3-[(4-methoxy-phenyl)-diphenyl-methoxy]-hexahydro-1,5,7,9-tetraoxa-6,8-disila-benzocycloocten-2-yl}-1H-pyrimidine-2,4-dione(1055039-72-9)
• EPA Substance Registry System: 1-{(2R,3R,4R,4aR,10aR)-4-Hydroxy-6,6,8,8-tetraisopropyl-3-[(4-methoxy-phenyl)-diphenyl-methoxy]-hexahydro-1,5,7,9-tetraoxa-6,8-disila-benzocycloocten-2-yl}-1H-pyrimidine-2,4-dione(1055039-72-9)

Safety Data

• Hazardous Substances Data: 1055039-72-9(Hazardous Substances Data)

Upstream product

• 23707-26-8 1-(2’,3’,4’,6’-tetra-O-acetyl-β-D-galactopyranosyl)-uracil 
• 33000-97-4 1-(β-D-galactopyranosyl)uracil 
• 4163-60-4 β-D-galactose peracetate 
• 160308-30-5 1-<4,6-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-galactopyranosyl>uracil 
• 14470-28-1 mono-4-methoxytrityl chloride 

Downstream Products

• 160308-36-1 1-<2-O-(4-methoxytrityl)-β-D-galactopyranosyl>uracil 

Relevant articles and documents

New Acyclic Nucleoside Analogues. Stereospecific Synthesis of Purines and Pyrimidines Substituted with Chiral Chains by Sugar-ring Opening of &β-D-Galactopyranosyl Nucleosides

2',3'- and 3',4'-Seco-nucleosides, retaining the carbon framework of β-D-ribofuranosyl nucleosides but having a hydroxymethyl substituent on the 4' or 5' position, have been synthesized and their antiviral properties examined.These hitherto unknown chiral acyclic nucleosides were stereospecifically prepared by ring opening of β-D-galactopyranosyl nucleosides by means of periodate oxidation followed by borohydride reduction.None of the prepared compounds showed marked antiviral effect against a variety of DNA and RNA viruses.